Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips

Tuberculosis

Volumn 87, Issue 1, 2007, Pages 63-70

  Fu, Li M ^a   Shinnick, Thomas M ^b  

^a Pacific Tuberculosis and Cancer Research Organization   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Drug; Gene expression; Genome; INH; Isoniazid; Microarray; Resistance; Tuberculosis

Indexed keywords

CATALASE; FATTY ACID SYNTHASE; ISONIAZID; PRODRUG;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION PROFILING; GENE SEQUENCE; INFECTION RESISTANCE; MICROARRAY ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BASE SEQUENCE; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; FATTY ACID SYNTHETASE COMPLEX, TYPE II; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, BACTERIAL;

EID: 33845665220     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2006.04.001     Document Type: Article

References (22)

1. Seaworth B.J. Multidrug-resistant tuberculosis. Infect Dis Clin North Am 16 1 (2002) 73-105
2. Frieden T.R., Sherman L.F., Maw K.L., et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. Jam Med Assoc 276 15 (1996) 1229-1235
3. Espinal M.A., Kim S.J., Suarez P.G., et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. Jam Med Assoc 283 19 (2000) 2537-2545
4. Sterling T.R., Lehmann H.P., and Frieden T.R. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. Br Med J 326 7389 (2003) 574
5. Wilson M., DeRisi J., Kristensen H.H., et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Nat Acad Sci USA 96 22 (1999) 12833-12838
6. Boshoff H.I., Myers T.G., Copp B.R., McNeil M.R., Wilson M.A., and Barry III C.E. The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279 38 (2004) 40174-40184
7. Maus C.E., Plikaytis B.B., and Shinnick T.M. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49 2 (2005) 571-577
8. Fisher M.A., Plikaytis B.B., and Shinnick T.M. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J Bacteriol 184 14 (2002) 4025-4032
9. Cole S.T., Brosch R., Parkhill J., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 6685 (1998) 537-544
10. Heym B., Honore N., Truffot-Pernot C., et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344 8918 (1994) 293-298
11. Betts J.C., McLaren A., Lennon M.G., et al. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother 47 9 (2003) 2903-2913
12. Waddell S.J., Stabler R.A., Laing K., Kremer L., Reynolds R.C., and Besra G.S. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinburgh) 84 3-4 (2004) 263-274
13. Fu L.M. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips. Tuberculosis Edinburgh 86 2 (2006) 134-143
14. In: Sussman M. (Ed). Molecular medical microbiology vol. 1 (2002), Academic Press, San Diego
15. Heym B., Saint-Joanis B., and Cole S.T. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Tuber Lung Dis 79 4 (1999) 267-271
16. Slayden R.A., and Barry III C.E. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect 2 6 (2000) 659-669
17. Lee A.S., Lim I.H., Tang L.L., Telenti A., and Wong S.Y. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother 43 8 (1999) 2087-2089
18. Gingeras T.R., Ghandour G., Wang E., et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res 8 5 (1998) 435-448
19. Troesch A., Nguyen H., Miyada C.G., et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 37 1 (1999) 49-55
20. Moulding T.S. Should isoniazid be used in retreatment of tuberculosis despite acquired isoniazid resistance?. Am Rev Respir Dis 123 3 (1981) 262-264
21. Seth V., Beotra A., Seth S.D., et al. Serum concentrations of rifampicin and isoniazid in tuberculosis. Indian Pediatr 30 9 (1993) 1091-1098
22. DeRisi J.L., Iyer V.R., and Brown P.O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278 5338 (1997) 680-686